[1]
El-Menyar A, Mekkodathil A, Al-Thani H. Diagnosis and management of gastrointestinal stromal tumors: An up-to-date literature review. Journal of cancer research and therapeutics. 2017 Oct-Dec:13(6):889-900. doi: 10.4103/0973-1482.177499. Epub
[PubMed PMID: 29237949]
[2]
Schaefer IM, Mariño-Enríquez A, Fletcher JA. What is New in Gastrointestinal Stromal Tumor? Advances in anatomic pathology. 2017 Sep:24(5):259-267. doi: 10.1097/PAP.0000000000000158. Epub
[PubMed PMID: 28632504]
Level 3 (low-level) evidence
[3]
Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2016 Jan:19(1):3-14. doi: 10.1007/s10120-015-0526-8. Epub 2015 Aug 15
[PubMed PMID: 26276366]
[4]
Demetri GD,von Mehren M,Antonescu CR,DeMatteo RP,Ganjoo KN,Maki RG,Pisters PW,Raut CP,Riedel RF,Schuetze S,Sundar HM,Trent JC,Wayne JD, NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. Journal of the National Comprehensive Cancer Network : JNCCN. 2010 Apr;
[PubMed PMID: 20457867]
[5]
Miettinen M, Lasota J. Histopathology of gastrointestinal stromal tumor. Journal of surgical oncology. 2011 Dec:104(8):865-73. doi: 10.1002/jso.21945. Epub
[PubMed PMID: 22069171]
[6]
Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet (London, England). 2013 Sep 14:382(9896):973-83. doi: 10.1016/S0140-6736(13)60106-3. Epub 2013 Apr 24
[PubMed PMID: 23623056]
[7]
Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of pathology & laboratory medicine. 2006 Oct:130(10):1466-78
[PubMed PMID: 17090188]
[8]
Akahoshi K,Oya M,Koga T,Shiratsuchi Y, Current clinical management of gastrointestinal stromal tumor. World journal of gastroenterology. 2018 Jul 14;
[PubMed PMID: 30018476]
[9]
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY, ESMO Guidelines Committee and EURACAN. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1:29(Suppl 4):iv68-iv78. doi: 10.1093/annonc/mdy095. Epub
[PubMed PMID: 29846513]
Level 1 (high-level) evidence
[10]
Iwatsuki M, Harada K, Iwagami S, Eto K, Ishimoto T, Baba Y, Yoshida N, Ajani JA, Baba H. Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors. Annals of gastroenterological surgery. 2019 Jan:3(1):43-49. doi: 10.1002/ags3.12211. Epub 2018 Sep 27
[PubMed PMID: 30697609]
[11]
Ohtani H, Maeda K, Noda E, Nagahara H, Shibutani M, Ohira M, Muguruma K, Tanaka H, Kubo N, Toyokawa T, Sakurai K, Yamashita Y, Yamamoto A, Hirakawa K. Meta-analysis of laparoscopic and open surgery for gastric gastrointestinal stromal tumor. Anticancer research. 2013 Nov:33(11):5031-41
[PubMed PMID: 24222147]
Level 1 (high-level) evidence
[12]
Nishida T, Hirota S, Yanagisawa A, Sugino Y, Minami M, Yamamura Y, Otani Y, Shimada Y, Takahashi F, Kubota T, GIST Guideline Subcommittee. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. International journal of clinical oncology. 2008 Oct:13(5):416-30. doi: 10.1007/s10147-008-0798-7. Epub 2008 Oct 23
[PubMed PMID: 18946752]
Level 1 (high-level) evidence
[13]
Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Feb 1:26(4):626-32. doi: 10.1200/JCO.2007.13.4452. Epub
[PubMed PMID: 18235122]
Level 1 (high-level) evidence
[14]
Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PC, Van Glabbeke M, Bertulli R, Judson I. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet (London, England). 2004 Sep 25-Oct 1:364(9440):1127-34
[PubMed PMID: 15451219]
Level 1 (high-level) evidence
[15]
Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2009 Mar 28:373(9669):1097-104. doi: 10.1016/S0140-6736(09)60500-6. Epub 2009 Mar 18
[PubMed PMID: 19303137]
Level 1 (high-level) evidence
[16]
Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alvegård T, Reichardt P. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012 Mar 28:307(12):1265-72. doi: 10.1001/jama.2012.347. Epub
[PubMed PMID: 22453568]
Level 1 (high-level) evidence
[17]
Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, Fumagalli E, Nyckowski P, Nguyen BP, Kerst JM, Fiore M, Bylina E, Hoiczyk M, Cats A, Casali PG, Le Cesne A, Treckmann J, Stoeckle E, de Wilt JH, Sleijfer S, Tielen R, van der Graaf W, Verhoef C, van Coevorden F. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Annals of surgical oncology. 2013 Sep:20(9):2937-43. doi: 10.1245/s10434-013-3013-7. Epub 2013 Jun 13
[PubMed PMID: 23760587]
[18]
Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 May 1:25(13):1753-9
[PubMed PMID: 17470865]
[19]
Gheorghe M, Predescu D, Iosif C, Ardeleanu C, Băcanu F, Constantinoiu S. Clinical and therapeutic considerations of GIST. Journal of medicine and life. 2014 Jun 15:7(2):139-49
[PubMed PMID: 25408717]
[20]
Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. The Lancet. Oncology. 2009 Nov:10(11):1045-52. doi: 10.1016/S1470-2045(09)70242-6. Epub 2009 Sep 28
[PubMed PMID: 19793678]
Level 2 (mid-level) evidence
[21]
Sorour MA, Kassem MI, Ghazal Ael-H, El-Riwini MT, Abu Nasr A. Gastrointestinal stromal tumors (GIST) related emergencies. International journal of surgery (London, England). 2014:12(4):269-80. doi: 10.1016/j.ijsu.2014.02.004. Epub 2014 Feb 12
[PubMed PMID: 24530605]
[22]
Mullady DK, Tan BR. A multidisciplinary approach to the diagnosis and treatment of gastrointestinal stromal tumor. Journal of clinical gastroenterology. 2013 Aug:47(7):578-85. doi: 10.1097/MCG.0b013e3182936c87. Epub
[PubMed PMID: 23751846]
[23]
Reichardt P, Morosi C, Wardelmann E, Gronchi A. Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in management. Expert review of anticancer therapy. 2012 Aug:12(8):1053-68. doi: 10.1586/era.12.48. Epub 2012 May 14
[PubMed PMID: 22582922]